Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a study.

Scheltens P, Hallikainen M, Grimmer T, Duning T, Gouw AA, Teunissen CE, Wink AM, Maruff P, Harrison J, van Baal CM, Bruins S, Lues I, Prins ND.

Alzheimers Res Ther. 2018 Oct 12;10(1):107. doi: 10.1186/s13195-018-0431-6.

2.

Clinical correlates of quantitative EEG in Parkinson disease: A systematic review.

Geraedts VJ, Boon LI, Marinus J, Gouw AA, van Hilten JJ, Stam CJ, Tannemaat MR, Contarino MF.

Neurology. 2018 Nov 6;91(19):871-883. doi: 10.1212/WNL.0000000000006473. Epub 2018 Oct 5.

PMID:
30291182
3.

EEG Characteristics of Dementia With Lewy Bodies, Alzheimer's Disease and Mixed Pathology.

van der Zande JJ, Gouw AA, van Steenoven I, Scheltens P, Stam CJ, Lemstra AW.

Front Aging Neurosci. 2018 Jul 3;10:190. doi: 10.3389/fnagi.2018.00190. eCollection 2018.

4.

Practical guidelines for clinical magnetoencephalography - Another step towards best practice.

Hillebrand A, Gaetz W, Furlong PL, Gouw AA, Stam CJ.

Clin Neurophysiol. 2018 Aug;129(8):1709-1711. doi: 10.1016/j.clinph.2018.05.007. Epub 2018 Jun 2. No abstract available.

PMID:
29903504
5.

Quantitative EEG reflects non-dopaminergic disease severity in Parkinson's disease.

Geraedts VJ, Marinus J, Gouw AA, Mosch A, Stam CJ, van Hilten JJ, Contarino MF, Tannemaat MR.

Clin Neurophysiol. 2018 Aug;129(8):1748-1755. doi: 10.1016/j.clinph.2018.04.752. Epub 2018 May 29.

PMID:
29887401
6.

Medial temporal lobe atrophy relates more strongly to sleep-wake rhythm fragmentation than to age or any other known risk.

Van Someren EJW, Oosterman JM, Van Harten B, Vogels RL, Gouw AA, Weinstein HC, Poggesi A, Scheltens P, Scherder EJA.

Neurobiol Learn Mem. 2019 Apr;160:132-138. doi: 10.1016/j.nlm.2018.05.017. Epub 2018 Jun 1.

7.

Gray matter network measures are associated with cognitive decline in mild cognitive impairment.

Dicks E, Tijms BM, Ten Kate M, Gouw AA, Benedictus MR, Teunissen CE, Barkhof F, Scheltens P, van der Flier WM.

Neurobiol Aging. 2018 Jan;61:198-206. doi: 10.1016/j.neurobiolaging.2017.09.029. Epub 2017 Oct 6.

PMID:
29111486
8.

Gray matter networks and clinical progression in subjects with predementia Alzheimer's disease.

Tijms BM, Ten Kate M, Gouw AA, Borta A, Verfaillie S, Teunissen CE, Scheltens P, Barkhof F, van der Flier WM.

Neurobiol Aging. 2018 Jan;61:75-81. doi: 10.1016/j.neurobiolaging.2017.09.011. Epub 2017 Sep 20.

PMID:
29040871
9.

Altering neuronal excitability to preserve network connectivity in a computational model of Alzheimer's disease.

de Haan W, van Straaten ECW, Gouw AA, Stam CJ.

PLoS Comput Biol. 2017 Sep 22;13(9):e1005707. doi: 10.1371/journal.pcbi.1005707. eCollection 2017 Sep.

10.

Functional and effective whole brain connectivity using magnetoencephalography to identify monozygotic twin pairs.

Demuru M, Gouw AA, Hillebrand A, Stam CJ, van Dijk BW, Scheltens P, Tijms BM, Konijnenberg E, Ten Kate M, den Braber A, Smit DJA, Boomsma DI, Visser PJ.

Sci Rep. 2017 Aug 29;7(1):9685. doi: 10.1038/s41598-017-10235-y.

11.

Directional information flow in patients with Alzheimer's disease. A source-space resting-state MEG study.

Engels MMA, Yu M, Stam CJ, Gouw AA, van der Flier WM, Scheltens P, van Straaten ECW, Hillebrand A.

Neuroimage Clin. 2017 Jun 17;15:673-681. doi: 10.1016/j.nicl.2017.06.025. eCollection 2017.

12.

EEG spectral analysis as a putative early prognostic biomarker in nondemented, amyloid positive subjects.

Gouw AA, Alsema AM, Tijms BM, Borta A, Scheltens P, Stam CJ, van der Flier WM.

Neurobiol Aging. 2017 Sep;57:133-142. doi: 10.1016/j.neurobiolaging.2017.05.017. Epub 2017 Jun 1.

PMID:
28646686
13.

Horizontal visibility graph transfer entropy (HVG-TE): A novel metric to characterize directed connectivity in large-scale brain networks.

Yu M, Hillebrand A, Gouw AA, Stam CJ.

Neuroimage. 2017 Aug 1;156:249-264. doi: 10.1016/j.neuroimage.2017.05.047. Epub 2017 May 21.

PMID:
28539247
14.

Selective impairment of hippocampus and posterior hub areas in Alzheimer's disease: an MEG-based multiplex network study.

Yu M, Engels MMA, Hillebrand A, van Straaten ECW, Gouw AA, Teunissen C, van der Flier WM, Scheltens P, Stam CJ.

Brain. 2017 May 1;140(5):1466-1485. doi: 10.1093/brain/awx050.

PMID:
28334883
15.

Low normal cerebrospinal fluid Aβ42 levels predict clinical progression in nondemented subjects.

Tijms BM, Bertens D, Slot RE, Gouw AA, Teunissen CE, Scheltens P, van der Flier WM, Visser PJ.

Ann Neurol. 2017 May;81(5):749-753. doi: 10.1002/ana.24921. Epub 2017 May 4.

PMID:
28318059
16.

Different functional connectivity and network topology in behavioral variant of frontotemporal dementia and Alzheimer's disease: an EEG study.

Yu M, Gouw AA, Hillebrand A, Tijms BM, Stam CJ, van Straaten EC, Pijnenburg YA.

Neurobiol Aging. 2016 Jun;42:150-62. doi: 10.1016/j.neurobiolaging.2016.03.018. Epub 2016 Mar 22.

PMID:
27143432
17.

EEG-directed connectivity from posterior brain regions is decreased in dementia with Lewy bodies: a comparison with Alzheimer's disease and controls.

Dauwan M, van Dellen E, van Boxtel L, van Straaten ECW, de Waal H, Lemstra AW, Gouw AA, van der Flier WM, Scheltens P, Sommer IE, Stam CJ.

Neurobiol Aging. 2016 May;41:122-129. doi: 10.1016/j.neurobiolaging.2016.02.017. Epub 2016 Feb 21.

PMID:
27103525
18.

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, Bakardjian H, Benali H, Bertram L, Blennow K, Broich K, Cavedo E, Crutch S, Dartigues JF, Duyckaerts C, Epelbaum S, Frisoni GB, Gauthier S, Genthon R, Gouw AA, Habert MO, Holtzman DM, Kivipelto M, Lista S, Molinuevo JL, O'Bryant SE, Rabinovici GD, Rowe C, Salloway S, Schneider LS, Sperling R, Teichmann M, Carrillo MC, Cummings J, Jack CR Jr; Proceedings of the Meeting of the International Working Group (IWG) and the American Alzheimer's Association on “The Preclinical State of AD”; July 23, 2015; Washington DC, USA.

Alzheimers Dement. 2016 Mar;12(3):292-323. doi: 10.1016/j.jalz.2016.02.002. Review.

19.

Direction of information flow in large-scale resting-state networks is frequency-dependent.

Hillebrand A, Tewarie P, van Dellen E, Yu M, Carbo EW, Douw L, Gouw AA, van Straaten EC, Stam CJ.

Proc Natl Acad Sci U S A. 2016 Apr 5;113(14):3867-72. doi: 10.1073/pnas.1515657113. Epub 2016 Mar 21.

20.

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer's disease: an emerging method based upon brain dynamics.

van Straaten EC, Scheltens P, Gouw AA, Stam CJ.

Alzheimers Res Ther. 2014 Dec 19;6(9):86. doi: 10.1186/s13195-014-0086-x. eCollection 2014.

21.

Diffusion changes predict cognitive and functional outcome: the LADIS study.

Jokinen H, Schmidt R, Ropele S, Fazekas F, Gouw AA, Barkhof F, Scheltens P, Madureira S, Verdelho A, Ferro JM, Wallin A, Poggesi A, Inzitari D, Pantoni L, Erkinjuntti T; LADIS Study Group.

Ann Neurol. 2013 May;73(5):576-83. doi: 10.1002/ana.23802. Epub 2013 Feb 19.

PMID:
23423951
22.

Low cerebrospinal fluid sulfatide predicts progression of white matter lesions: The LADIS study.

Jonsson M, Zetterberg H, Rolstad S, Edman A, Gouw AA, Bjerke M, Lind K, Blennow K, Pantoni L, Inzitari D, Wallin A.

Dement Geriatr Cogn Disord. 2012;34(1):61-7. doi: 10.1159/000341576. Epub 2012 Aug 22.

PMID:
22922641
23.

White matter lesion progression in LADIS: frequency, clinical effects, and sample size calculations.

Schmidt R, Berghold A, Jokinen H, Gouw AA, van der Flier WM, Barkhof F, Scheltens P, Petrovic K, Madureira S, Verdelho A, Ferro JM, Waldemar G, Wallin A, Wahlund LO, Poggesi A, Pantoni L, Inzitari D, Fazekas F, Erkinjuntti T; LADIS Study Group.

Stroke. 2012 Oct;43(10):2643-7. Epub 2012 Aug 9.

PMID:
22879094
24.

Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study.

Firbank MJ, Teodorczuk A, van der Flier WM, Gouw AA, Wallin A, Erkinjuntti T, Inzitari D, Wahlund LO, Pantoni L, Poggesi A, Pracucci G, Langhorne P, O'Brien JT; LADIS group.

Br J Psychiatry. 2012 Jul;201(1):40-5. doi: 10.1192/bjp.bp.111.098897. Epub 2012 May 24.

PMID:
22626634
25.

Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS study.

Jokinen H, Lipsanen J, Schmidt R, Fazekas F, Gouw AA, van der Flier WM, Barkhof F, Madureira S, Verdelho A, Ferro JM, Wallin A, Pantoni L, Inzitari D, Erkinjuntti T; LADIS Study Group.

Neurology. 2012 May 29;78(22):1785-92. doi: 10.1212/WNL.0b013e3182583070. Epub 2012 May 16.

PMID:
22592361
26.

The spatial distribution of age-related white matter changes as a function of vascular risk factors--results from the LADIS study.

Rostrup E, Gouw AA, Vrenken H, van Straaten EC, Ropele S, Pantoni L, Inzitari D, Barkhof F, Waldemar G; LADIS study group.

Neuroimage. 2012 Apr 15;60(3):1597-607. doi: 10.1016/j.neuroimage.2012.01.106. Epub 2012 Jan 28.

PMID:
22305990
27.

Incident lacunes influence cognitive decline: the LADIS study.

Jokinen H, Gouw AA, Madureira S, Ylikoski R, van Straaten EC, van der Flier WM, Barkhof F, Scheltens P, Fazekas F, Schmidt R, Verdelho A, Ferro JM, Pantoni L, Inzitari D, Erkinjuntti T; LADIS Study Group.

Neurology. 2011 May 31;76(22):1872-8. doi: 10.1212/WNL.0b013e31821d752f. Epub 2011 May 4.

PMID:
21543730
28.

Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations.

Gouw AA, Seewann A, van der Flier WM, Barkhof F, Rozemuller AM, Scheltens P, Geurts JJ.

J Neurol Neurosurg Psychiatry. 2011 Feb;82(2):126-35. doi: 10.1136/jnnp.2009.204685. Epub 2010 Oct 9. Review.

PMID:
20935330
29.

The first case of fatal familial insomnia (FFI) in the Netherlands: a patient from Egyptian descent with concurrent four repeat tau deposits.

Jansen C, Parchi P, Jelles B, Gouw AA, Beunders G, van Spaendonk RM, van de Kamp JM, Lemstra AW, Capellari S, Rozemuller AJ.

Neuropathol Appl Neurobiol. 2011 Aug;37(5):549-53. doi: 10.1111/j.1365-2990.2010.01126.x. No abstract available.

PMID:
20874730
30.

Assessing mental flexibility: neuroanatomical and neuropsychological correlates of the Trail Making Test in elderly people.

Oosterman JM, Vogels RL, van Harten B, Gouw AA, Poggesi A, Scheltens P, Kessels RP, Scherder EJ.

Clin Neuropsychol. 2010 Feb;24(2):203-19. doi: 10.1080/13854040903482848.

PMID:
20162494
31.

Vascular care in patients with Alzheimer disease with cerebrovascular lesions slows progression of white matter lesions on MRI: the evaluation of vascular care in Alzheimer's disease (EVA) study.

Richard E, Gouw AA, Scheltens P, van Gool WA.

Stroke. 2010 Mar;41(3):554-6. doi: 10.1161/STROKEAHA.109.571281. Epub 2010 Jan 7.

PMID:
20056923
32.

Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study.

Benisty S, Gouw AA, Porcher R, Madureira S, Hernandez K, Poggesi A, van der Flier WM, Van Straaten EC, Verdelho A, Ferro J, Pantoni L, Inzitari D, Barkhof F, Fazekas F, Chabriat H; LADIS Study group.

J Neurol Neurosurg Psychiatry. 2009 May;80(5):478-83. doi: 10.1136/jnnp.2008.160440. Epub 2009 Feb 11.

PMID:
19211595
33.

Quantitation of brain tissue changes associated with white matter hyperintensities by diffusion-weighted and magnetization transfer imaging: the LADIS (Leukoaraiosis and Disability in the Elderly) study.

Ropele S, Seewann A, Gouw AA, van der Flier WM, Schmidt R, Pantoni L, Inzitari D, Erkinjuntti T, Scheltens P, Wahlund LO, Waldemar G, Chabriat H, Ferro J, Hennerici M, O'Brien J, Wallin A, Langhorne P, Visser MC, Barkhof F, Fazekas F; LADIS study group.

J Magn Reson Imaging. 2009 Feb;29(2):268-74. doi: 10.1002/jmri.21580.

PMID:
19161174
34.

Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology.

Gouw AA, Seewann A, Vrenken H, van der Flier WM, Rozemuller JM, Barkhof F, Scheltens P, Geurts JJ.

Brain. 2008 Dec;131(Pt 12):3286-98. doi: 10.1093/brain/awn265. Epub 2008 Oct 16.

PMID:
18927145
35.

On the etiology of incident brain lacunes: longitudinal observations from the LADIS study.

Gouw AA, van der Flier WM, Pantoni L, Inzitari D, Erkinjuntti T, Wahlund LO, Waldemar G, Schmidt R, Fazekas F, Scheltens P, Barkhof F; LADIS study group.

Stroke. 2008 Nov;39(11):3083-5. doi: 10.1161/STROKEAHA.108.521807. Epub 2008 Aug 14.

PMID:
18703801
36.

Cerebral blood flow by using pulsed arterial spin-labeling in elderly subjects with white matter hyperintensities.

Bastos-Leite AJ, Kuijer JP, Rombouts SA, Sanz-Arigita E, van Straaten EC, Gouw AA, van der Flier WM, Scheltens P, Barkhof F.

AJNR Am J Neuroradiol. 2008 Aug;29(7):1296-301. doi: 10.3174/ajnr.A1091. Epub 2008 May 1.

37.

The role of white matter hyperintensities and medial temporal lobe atrophy in age-related executive dysfunctioning.

Oosterman JM, Vogels RL, van Harten B, Gouw AA, Scheltens P, Poggesi A, Weinstein HC, Scherder EJ.

Brain Cogn. 2008 Nov;68(2):128-33. doi: 10.1016/j.bandc.2008.03.006. Epub 2008 May 2.

PMID:
18450353
38.

Transcranial Doppler blood flow assessment in patients with mild heart failure: correlates with neuroimaging and cognitive performance.

Vogels RL, Oosterman JM, Laman DM, Gouw AA, Schroeder-Tanka JM, Scheltens P, van der Flier WM, Weinstein HC.

Congest Heart Fail. 2008 Mar-Apr;14(2):61-5.

PMID:
18401213
39.

Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study.

Gouw AA, van der Flier WM, Fazekas F, van Straaten EC, Pantoni L, Poggesi A, Inzitari D, Erkinjuntti T, Wahlund LO, Waldemar G, Schmidt R, Scheltens P, Barkhof F; LADIS Study Group.

Stroke. 2008 May;39(5):1414-20. doi: 10.1161/STROKEAHA.107.498535. Epub 2008 Mar 6.

PMID:
18323505
40.

Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression.

Gouw AA, van der Flier WM, van Straaten EC, Pantoni L, Bastos-Leite AJ, Inzitari D, Erkinjuntti T, Wahlund LO, Ryberg C, Schmidt R, Fazekas F, Scheltens P, Barkhof F; LADIS study group.

Cerebrovasc Dis. 2008;25(3):247-53. doi: 10.1159/000113863. Epub 2008 Jan 24.

PMID:
18216467
41.

Neuroimaging and correlates of cognitive function among patients with heart failure.

Vogels RL, Oosterman JM, van Harten B, Gouw AA, Schroeder-Tanka JM, Scheltens P, van der Flier WM, Weinstein HC.

Dement Geriatr Cogn Disord. 2007;24(6):418-23. Epub 2007 Oct 15.

PMID:
17938570
42.

Brain magnetic resonance imaging abnormalities in patients with heart failure.

Vogels RL, van der Flier WM, van Harten B, Gouw AA, Scheltens P, Schroeder-Tanka JM, Weinstein HC.

Eur J Heart Fail. 2007 Oct;9(10):1003-9. Epub 2007 Aug 23.

43.

Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study.

Gouw AA, Van der Flier WM, van Straaten EC, Barkhof F, Ferro JM, Baezner H, Pantoni L, Inzitari D, Erkinjuntti T, Wahlund LO, Waldemar G, Schmidt R, Fazekas F, Scheltens P; LADIS Study Group.

J Neurol. 2006 Sep;253(9):1189-96. Epub 2006 Sep 22.

PMID:
16998647

Supplemental Content

Support Center